Return to Diabetes Health

September 26, 2006

Diabetes Drug Avandia Touted as Preventative

GlaxoSmithKline is touting its diabetes drug Avandia as a way to prevent diabetes in those who are at risk. Some are asking if healthy people taking a pill with serious possible side effects is wise and are suggesting diet and exercise instead.

Indeed, a recent drug trial showed those taking Avandia had a slight increase in heart failure rates as well as weight gain. Putting people who don't even have diabetes at risk for these things is silly. It's just like putting postmenopausal women on Fosamax to prevent osteoporosis even though their bone density scores are fine.

Not enough sick people in the world? Drug companies will invent them!

From the viewpoint of pharmaceutical companies nothing looks better than a pill that healthy people take every day for the rest of their lives. Anti-cholesterol statins, with U.S. sales exceeding $15 billion a year, serve as the shining example. It is hardly surprising that GlaxoSmithKline, the manufacturer of Avandia, along with two other drug companies, paid for the DREAM trial and actively publicized the results.

Diabetes pill works — but is it worth the cost?

Posted by Staff at 11:14 AM | Comments (1)


logo
Diabetes Health is part of the Health Diaries network. Health Diaries publishes blogs, articles, and news on health and fitness topics.

About
Advertise
Contact
Contribute
Sitemap


get well cards
Tell someone you're thinking of them with one of our free get well cards. We also have sympathy cards and blank cards if you want to send thanks or just a hello.
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Copyright © 2004-2007 HealthDiaries.com and the authors. All rights reserved.